Gastroenterology Doctors in Chesterfield, MI Accepting Medicare

1 Gastroenterology doctors found. Showing 1 - 1

Dr. Ronald Fogel, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 30795 23 Mile Rd, Suite 206, Chesterfield, MI 48047 Phone: 586-598-5731    Fax: 586-948-1530

News Archive

Calypso Medical Technologies presents its real-time tracking technology at 51st ASTRO annual meeting

Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, today announced Calypso's real-time tracking technology is included in 36 scientific presentations and posters at the 51st Annual Meeting of the American Society for Therapeutic Radiation Oncology (ASTRO), now underway at McCormick Place in Chicago.

Bristol-Myers Squibb to present new immunotherapy study data at ASCO Annual Meeting

Bristol-Myers Squibb Company today announced that new data from studies investigating its immunotherapies in adjuvant and advanced melanoma, non-small cell lung cancer (NSCLC) and metastatic renal cell carcinoma (mRCC) will be presented at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago from May 30-June 3.

Free educational webinar: Important aspects to be aware of when selecting EHR system

Community oncologists, practice administrators (PAs), executive directors (EDs), and clinical staff interested in learning the most important aspects to be aware of when selecting the Electronic Health Record (EHR) system most appropriate for your particular practice are invited to attend a free webinar at 2 p.m. EST (11 a.m. PST) on Thursday, Feb. 18, 2010.

NYSE Amex accepts Palatin's exchange listing compliance plan

Palatin Technologies, Inc. reported that its exchange listing compliance plan has been accepted by the NYSE Amex. Palatin has been granted an extension until May 26, 2011 to regain compliance with stockholders' equity requirements under Section 1003(a)(iii) of the NYSE Amex Company Guide and until February 28, 2011 to regain compliance with financial condition continued listing requirements under Section 1003(a)(iv).

Biothera enhances innate immune responses to Imprime PGG drug candidate

Biothera has enhanced innate immune responses to its cancer immunotherapy drug candidate Imprime PGG in subjects regardless of biomarker status, demonstrating the opportunity to treat a larger patient population. The in vitro research will be presented today at the Cambridge Healthtech Institute's Antibody-Drug Conjugates/Engineering Targeted Therapeutics conference in Palm Springs, CA.

Read more Medical News

› Verified 8 days ago